Hepatitis A Vaccine Market - Global Professional Analysis and Forecast to 2026
- REPORT SUMMARY
- TABLE OF CONTENTS
- INDUSTRY COVERAGE
The worldwide Hepatitis A Vaccine market was valued at 684 Million US$ in 2018 and is projected to reach 849 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.75% during the forecast period.
This report presents the market size and development trends by detailing the Hepatitis A Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Hepatitis A Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Hepatitis A Vaccine industry and will help you to build a panoramic view of the industrial development.
Hepatitis A Vaccine Market, By Type:
Only for Hepatitis A
Combination Vaccine
Others
Hepatitis A Vaccine Market, By Application:
Clinics and Hospital
Public Service
Others
Some of the leading players are as follows:
Sanofi Pasteur
Pukang Biotec
GlaxoSmithKline
Merck & Co.
Sinovac Biotech
Aventis Pasteur India Ltd
Crucell
Janssen Pharmaceutical Companies
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Hepatitis A Vaccine Market: Technology Type Analysis
-
4.1 Hepatitis A Vaccine Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Hepatitis A Vaccine Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Only for Hepatitis A
4.3.2 Combination Vaccine
4.3.3 Others
5 Hepatitis A Vaccine Market: Product Analysis
-
5.1 Hepatitis A Vaccine Product Market Share Analysis, 2018 & 2026
-
5.2 Hepatitis A Vaccine Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Hepatitis A Vaccine Market: Application Analysis
-
6.1 Hepatitis A Vaccine Application Market Share Analysis, 2018 & 2026
-
6.2 Hepatitis A Vaccine Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Clinics and Hospital
6.3.2 Public Service
6.3.3 Others
7 Hepatitis A Vaccine Market: Regional Analysis
-
7.1 Hepatitis A Vaccine Regional Market Share Analysis, 2018 & 2026
-
7.2 Hepatitis A Vaccine Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Sanofi Pasteur
9.1.1 Sanofi Pasteur Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Pukang Biotec
9.2.1 Pukang Biotec Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 GlaxoSmithKline
9.3.1 GlaxoSmithKline Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Merck & Co.
9.4.1 Merck & Co. Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Sinovac Biotech
9.5.1 Sinovac Biotech Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Aventis Pasteur India Ltd
9.6.1 Aventis Pasteur India Ltd Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Crucell
9.7.1 Crucell Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Janssen Pharmaceutical Companies
9.8.1 Janssen Pharmaceutical Companies Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
The List of Tables and Figures (Totals 70 Figures and 145 Tables)
Figure Only for Hepatitis A Hepatitis A Vaccine market, 2015 - 2026 (USD Million)
Figure Combination Vaccine Hepatitis A Vaccine market, 2015 - 2026 (USD Million)
Figure Others Hepatitis A Vaccine market, 2015 - 2026 (USD Million)
Figure Clinics and Hospital market, 2015 - 2026 (USD Million)
Figure Public Service market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Hepatitis A Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table North America Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table North America Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table North America Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Canada Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Canada Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Europe Hepatitis A Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Europe Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Europe Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Europe Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Germany Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Germany Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table France Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table France Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Italy Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Italy Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Spain Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Spain Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Hepatitis A Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table China Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table China Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Japan Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Japan Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table India Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table India Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Hepatitis A Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table MEA Hepatitis A Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table MEA Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table MEA Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table MEA Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Hepatitis A Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Hepatitis A Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Hepatitis A Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Sanofi Pasteur Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pukang Biotec Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sinovac Biotech Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aventis Pasteur India Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Crucell Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Janssen Pharmaceutical Companies Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis